Endoscopic Frontal Sinus Surgery Draf III in Moderate to Severe Eosinophilic Chronic Rhinosinusitis With Polyps

Sponsor
Ibrahim Talal Elshamy (Other)
Overall Status
Recruiting
CT.gov ID
NCT05979662
Collaborator
(none)
50
2
2
32.9
25
0.8

Study Details

Study Description

Brief Summary

The aim of this study is to evaluate the effect of the primary endoscopic frontal sinus surgery on the clinical outcome in patients having moderate to severe eosinophilic chronic rhinosinusitis with polyps with primary outcome measures in form of recurrence of polyp using endoscopic polyp score and Secondary outcome measures include Lund MacKay score, SNOT-22 and need for corticosteroid to control polyp postoperatively.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Endoscopic frontal sinus surgery grade 6(Draf III).
  • Procedure: Endoscopic frontal sinus surgery grade 1-3(Draf I or IIa)
N/A

Detailed Description

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a common inflammatory disorder, affecting about 4% of the population worldwide and strongly impacts the quality of life of affected patient.

Eosinophilic chronic rhinosinusitis (ECRS) is a subtype of recalcitrant Chronic rhinosinusitis . Patients with ECRS and generally having a tissue eosinophil >10 cells per high power field (HPF), have worse disease severity and poorer treatment outcomes compared to non-Eosinophilic chronic rhinosinusitis.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Clinical Evaluation of Primary Endoscopic Frontal Sinus Surgery Grade 6 (Draf III) in Patients With Moderate to Severe Eosinophilic Chronic Rhinosinusitis With Polyps
Actual Study Start Date :
Jan 1, 2021
Anticipated Primary Completion Date :
Sep 30, 2023
Anticipated Study Completion Date :
Sep 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group one

Patients will undergo endoscopic frontal sinus surgery grade 6(Draf III).

Procedure: Endoscopic frontal sinus surgery grade 6(Draf III).
Patients will receive endoscopic frontal sinus surgery grade 6(Draf III).

Active Comparator: Group two

Patients will undergo endoscopic frontal sinus surgery grade 1-3(Draf I or IIa).

Procedure: Endoscopic frontal sinus surgery grade 1-3(Draf I or IIa)
Patients will receive endoscopic frontal sinus surgery grade 1-3(Draf I or IIa).

Outcome Measures

Primary Outcome Measures

  1. Recurrence of polyp using endoscopic polyp score [One year postoperatively]

    Polyps were evaluated on each side through nasal endoscopy at each visit and graded based on polyp size, resulting in scores of 0 to 4 9. Zero is no polyp, 1 = small polyps in the middle meatus not reaching below the inferior border of the middle turbinate, 2 = polyps reaching below the lower border of the middle turbinate, 3 = large polyps reaching the lower border of the inferior turbinate or polyps medial to the middle turbinate, and 4 = large polyps causing complete obstruction of the inferior nasal cavity. The sum of the left and right nostril scores is the Nasal Polyp Score

Secondary Outcome Measures

  1. Lund MacKay score [One year postoperatively]

    The Lund-Mackay staging system scores each sinus (anterior ethmoid, posterior ethmoid, maxillary, frontal, and sphenoid sinuses) according to the following scale: 0 (no opacification), 1 (partial opacification), or 2 (complete opacification).

  2. Sinonasal Outcome Test- 22 [One year postoperatively]

    SNOT- 22 was measured based on a 0-5 scale, where 0 defines no problems with the given symptom and 5 defines maximal problems

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

• Patients with moderate or severe eosinophilic chronic rhinosinusitis with polyps who failed appropriate medical treatment in the form of antibiotic, systemic and local corticosteroid for 3 months .

Exclusion Criteria:
  • Narrow anteroposterior diameter of frontal sinus ostium(1cm or less)

  • Patients showing less or highest degree of radiological complexity of surgery on studying the Computed Tomography.

  • Any contraindication for general anesthesia.

  • Patients below age of 18 years.

  • Incomplete follow up

  • previous sinus surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tanta University Hospitals Tanta El-Gharbia Egypt 31511
2 Tanta University Tanta El-Gharbia Egypt 31511

Sponsors and Collaborators

  • Ibrahim Talal Elshamy

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ibrahim Talal Elshamy, Assistant Lecturer of Otorhinolaryngology, Tanta University
ClinicalTrials.gov Identifier:
NCT05979662
Other Study ID Numbers:
  • 34417/1/21
First Posted:
Aug 7, 2023
Last Update Posted:
Aug 7, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 7, 2023